Robust drug bioavailability and safety for rheumatoid arthritis therapy using D-amino acids-based supramolecular hydrogels

Long-term use of disease-modifying anti-rheumatic drugs (DMARDs) such as methotrexate (MTX) shows clinical benefits for rheumatoid arthritis (RA) treatment. However, there are growing concerns over the adverse effects of systemic drug administration. Therefore, a strategy that can enhance drug bioav...

Description complète

Détails bibliographiques

Auteurs principaux:	Shaodan Ma, Shunan Gu, Jinwei Zhang, Weizhong Qi, Zhaowei Lin, Weicheng Zhai, Jie Zhan, Qi Li, Yanbin Cai, Yao Lu
Format:	Artigo
Langue:	Inglês
Publié:	Elsevier 2022-06-01
Collection:	Materials Today Bio
Sujets:	Rheumatoid arthritis Supramolecular hydrogel d-amino acids Methotrexate Drug delivery system
Accès en ligne:	http://www.sciencedirect.com/science/article/pii/S2590006422000941
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!